Joining the effort to lay a groundwork for the use of PD-L1 and TMB biomarkers to guide protocols regarding the use of PD-L1 ICI in HNSCC, this retrospective study correlates the level of expression of these biomarkers with demographic and outcome data in a dedicated HNSCC population. This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.